This dramatic rise in BACE1 level with cytokine combinations suggested that pro-inflammatory conditions in AD could elevate astrocytic BACE1 and potentially increase amyloidogenic APP processing in astrocytes. This evidence concerns the gene BACE1 and Alzheimer disease.